Pharmaceutical Animation in the UK: Costs, Timelines and ABPI Review (2026)
Original 3D animation © 2026 Kenzo Studio Ltd
The short answer
A 60–90 second pharmaceutical animation from a UK studio typically costs £8,000–£50,000, and takes 4–14 weeks from brief to certified file.
The spread is wide for two reasons. The science: a patient explainer in 2D is a different job from a 3D mechanism of action (MoA) with receptors, pathways and cell types that all have to behave correctly. And the review: promotional material in the UK has to pass medical, legal and regulatory (MLR) review and be certified under the ABPI (Association of the British Pharmaceutical Industry) Code before anyone sees it.
Most budgets that go wrong don't go wrong in animation. They go wrong in review, when a claim changes after the frames are built.
This guide covers what each type of pharma animation costs, where the weeks go, what the ABPI Code asks of a video, and how to brief a studio so the review goes once rather than four times.
Original 3D animation © 2026 Kenzo Studio Ltd
What each type of pharma animation costs in the UK
A 3D mechanism of action film is the most expensive single piece most brand teams commission; patient education in 2D is the least. Ranges below are for a professional UK studio, 60–90 seconds, one language, as of September 2026.
Mechanism of action (MoA), 3D — £20,000–£50,000+. How the drug works at molecular and cellular level. For healthcare professionals (HCPs), medical affairs and investors. Heavy review: every on-screen claim referenced.
Mechanism of disease (MoD), 3D — £15,000–£35,000. The pathway or condition the drug targets. For HCPs and disease awareness. Moderate to heavy review.
Medical device or procedure, 3D — £15,000–£40,000. A device, implant or technique in use. For surgeons, nurses and sales teams. Moderate review.
Patient education, 2D — £8,000–£20,000. A condition, a treatment journey, what to expect. For patients and carers. Non-promotional, but still reviewed.
Cut-downs and variants — £2,000–£10,000 each. Shorter edits, other languages, HCP and patient versions. Each version is reviewed on its own.
Three things push a project past these ranges: photoreal rendering, more than one market's regulatory requirements, and runtimes beyond two minutes. Congress booth loops and multi-screen installations are quoted per build, and usually sit above a single MoA film.
For comparison, a general UK animated explainer runs £8,000–£25,000 — see How much does an animated explainer video cost in the UK? Pharma sits higher because of the scientific accuracy and the review cycles, not the animation itself.
Original 3D animation © 2026 Kenzo Studio Ltd
What actually drives the price
Five things, roughly in order of how much they move the number.
How much science is on screen. One receptor binding one molecule is a day of modelling. Three pathways, two cell types and a downstream immune response is a fortnight. Price follows the number of distinct things that have to be built and shown to be right.
How many review rounds. Each MLR round adds studio time: updating frames, re-exporting, re-referencing. Two rounds is normal. Four is where budgets break.
Style. Stylised 3D is quicker than photoreal. 2D motion graphics are quicker than either. The right choice depends on what the audience needs to believe, not what looks most expensive.
Versions. An HCP film and a patient film are two films, with two scripts and two reviews. So are two markets. Planning versions up front costs less than adding them later.
Runtime. It matters less than people expect. Pre-production — script, references, style frames — costs roughly the same for 45 seconds as for 90, so short pieces cost more per second.
What doesn't drive the price much: the voiceover, the music, and the software. Those are small lines on any honest quote.
Original 3D animation © 2026 Kenzo Studio Ltd
How long it takes, and where the weeks go
A 90-second MoA film usually takes 4–14 weeks. Around half of that is the client's review process, not production.
Brief and references (1 week). The studio needs the claims, the source papers and the approved core visual, if one exists.
Referenced script (1–2 weeks). Every scientific statement is numbered against a reference before anyone draws anything.
MLR round 1 on the script (1–3 weeks). The cheapest point to change a claim. Words cost nothing to rewrite.
Storyboard and style frames (2 weeks). Key frames show the molecules, cells and camera moves in their final look.
MLR round 2 on the storyboard (1–3 weeks). Reviewers check that the pictures don't claim more than the words.
Animation, sound and voiceover (3–4 weeks).
Final review and certification (1–2 weeks). The final form of the video is certified, along with a written transcript.
The weeks that can be saved are in steps 3 and 5. If the claims are locked at script stage, the storyboard review is a check rather than a rewrite, and nothing built in step 6 has to be thrown away.
Original 3D animation © 2026 Kenzo Studio Ltd
What the ABPI Code asks of a video
In the UK, promotional video for prescription medicines is governed by the 2024 ABPI Code of Practice, administered by the PMCPA (Prescription Medicines Code of Practice Authority). It came into full force on 1 January 2025 and is the version in use today.
The parts that change how a video is made:
Certification of the final form. Promotional material, audiovisual included, has to be certified by a signatory in its final form. For video, a written transcript is certified too, including any graphs or tables that appear on screen. Any change after certification means certifying again.
Every claim substantiated. Anything the animation shows about efficacy or mechanism has to be backed by a reference. That includes what the pictures imply, not just what the voiceover says.
Prescribing information. Under the 2024 Code, prescribing information for certain digital material can be given via a QR code, which frees up end frames.
Adverse event reporting. Promotional material carries the adverse event reporting statement, and the black triangle where a medicine is under additional monitoring.
HCPs and the public are different audiences. Prescription-only medicines can't be advertised to the public in the UK. A patient film is disease or treatment education, written and reviewed as such — not the HCP film with the jargon removed.
What a studio should deliver to make this easy: a referenced script with numbered claims, a frame-accurate transcript, a version log, end frames with job code and date of preparation, and separate masters for each audience.
This is a summary for planning production, not regulatory advice. Your signatory and medical team decide what passes.
Original 3D animation © 2026 Kenzo Studio Ltd
Can AI make pharma animation cheaper?
Yes, in the early stages. Not yet in the final frames.
Where AI video tools genuinely save time and money:
Previz and animatics. Rough moving storyboards in days rather than weeks, so reviewers see the idea before it's built.
Style exploration. Five looks for a disease-awareness film instead of one, at the pitch stage.
Guide voiceovers and draft localisation, replaced by professional versions before certification.
Where it doesn't, yet:
Scientific accuracy. Generative tools invent plausible-looking molecules and cells. A reviewer has to trust that what's on screen matches the reference, and that has to be built, not generated.
Consistency across versions. A certified film may need an update in six months. Built 3D assets can be changed frame by frame. Generated footage often can't be reproduced.
Confidentiality. Unpublished data and pipeline assets shouldn't go into public AI tools. Ask any studio where your material is processed.
The sensible approach is a hybrid: AI to get to an approved storyboard faster, conventional 3D for anything that gets certified.
Original 3D animation © 2026 Kenzo Studio Ltd
How to brief a studio so review goes once
A good brief fits on two pages and answers seven questions. Studios will quote more accurately, and the first MLR round will be shorter.
Who is it for? HCPs, patients, sales force, investors. One primary audience per film.
Is it promotional? This decides the review route and what can be said.
What are the approved claims? The exact wording, with references. The studio shouldn't be writing claims.
What already exists? An approved core visual, brand assets, earlier MoA films, 3D models from other agencies.
Which versions and markets? Languages, audiences, cut-down lengths. Decide now.
Who reviews, and how long do they take? Names of the medical, legal and regulatory reviewers, and their usual turnaround.
Where will it play? Rep iPad, congress booth, website, social. This sets format, runtime and whether sound can be relied on.
Then ask the studio three things back: how they reference claims in a script, how many review rounds the quote includes, and whether they'll sign your NDA before you send the science.
Original 3D animation © 2026 Kenzo Studio Ltd
Frequently asked questions
How much does a mechanism of action animation cost in the UK?
A 60–90 second 3D MoA animation from a UK studio typically costs £20,000–£50,000. Simpler 2D versions can come in under £15,000. Complexity of the science and the number of review rounds move the price most.
How long does a pharmaceutical animation take to produce?
Usually 4–14 weeks from brief to certified file. Around half of that is MLR review. Locking claims at script stage is the biggest time saver.
Does a pharma animation need ABPI certification?
If it's promotional material for a prescription medicine in the UK, yes. The final form of the video and a written transcript are certified under the ABPI Code. Non-promotional material still goes through the company's own review.
Can one animation work for both doctors and patients?
Rarely well. Prescription-only medicines can't be promoted to the UK public, and the two audiences need different language and depth. Plan two films that share 3D assets.
Should a pharma animation be 2D or 3D?
3D when the audience needs to understand structure: molecules, receptors, devices, anatomy. 2D when the story is a process or a patient journey. 2D is typically 30–50% cheaper.
Can AI be used to make pharmaceutical animation?
For storyboards, animatics and style tests, yes, and it saves weeks. For certified final frames, conventional 3D is still the safer route, because it's accurate, reproducible and keeps confidential data out of public tools.
Do I need a specialist medical animation studio?
You need a studio that references claims properly, understands MLR review and can hold an NDA. Some specialists have in-house medical illustrators; others work from your medical team's input. Ask to see how they handled review on a previous project.
Original 3D animation © 2026 Kenzo Studio Ltd
Working with Kenzo Studio
Most of our pharmaceutical work is under NDA, which makes it awkward to write a case study about. It's also the point.
We've made work for the NHS, and the pharma reel is on our pharmaceutical and medical animation page. More is shown on request, once an NDA is in place.
If you have a mechanism to explain and a review committee to get it past, send a brief — or just the problem, if the brief doesn't exist yet. We'll tell you what it should cost and how long it should take, including if the honest answer is that you don't need 3D.